Publications by authors named "Hiba Salaheldin Orsud"
Background: Immune checkpoint inhibitors (ICIs) have emerged as an effective treatment for colorectal cancer (CRC). Studies indicate that the composition of gut microbiota could potentially serve as a biomarker for predicting the clinical effectiveness of immune checkpoint inhibitors.
Methods: Following PRISMA guidelines, the review was conducted after registering the protocol with PROSPERO.